Nucletron names new executive VP of sales

TriMed Staff | | Health Imaging | Oncology Imaging
Radiotherapy systems developer Nucletron has appointed Peter Kingma as executive vice president of global sales and service.

Prior to joining the Veenendaal, Netherlands-based company, Kingma served as vice president and business manager of the CT division at Siemens Healthcare. In his new role at Nucletron, Kingma will manage global service and sales activities of cancer treatment technologies and will also serve as a member of the executive management team.

TriMed Staff

Related Content

New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging
Tiny 'water bears' may hold key to reducing radiation-induced side effects
High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.